synthetic glycolipid prevents autoimmune encephalomyelitis inducing th bias natural killer t cells 
experimental autoimmune encephalomyelitis eae prototype autoimmune disease mediated type helper t th cells control regulatory cells- report synthetic glycolipid ligand cd1d-restricted natural killer t nkt cells expressing semi-invariant t-cell receptor v alpha + preventive eae ligand analogue alpha galactosylceramide alpha gc prototype nkt cell ligand truncated sphingosine chain alpha gc causes nkt cells produce interferon ifn-gamma interleukin il refs however new ligand can induce predominant production il nkt cells single injection glycolipid alpha gc consistently induced th bias autoimmune t cells causing nkt cells produce il- leading suppression eae lack polymorphism cd1d cross-reactive response mouse human nkt cells ligand indicates targeting nkt cells ligand may attractive means intervening human autoimmune diseases multiple sclerosis 
